Cargando…
A critical analysis of serogroup B meningococcal disease burden in Brazil (2001–2015): implications for public health decisions
The recent licensure of two different serogroup B recombinant protein meningococcal vaccines in Brazil emphasizes the importance of a better knowledge of the real burden of serogroup B meningococcal (MenB) disease to establish evidence-based vaccination policies. We performed an observational, descr...
Autores principales: | Chicuto, Luciana Andrea Digieri, de Moraes, Camile, Cássio de Moraes, José, Sáfadi, Marco Aurélio P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7482866/ https://www.ncbi.nlm.nih.gov/pubmed/31951784 http://dx.doi.org/10.1080/21645515.2019.1700710 |
Ejemplares similares
-
Evaluation of the impact of serogroup C meningococcal disease vaccination
program in Brazil and its regions: a population-based study,
2001-2013
por: de Moraes, Camile, et al.
Publicado: (2017) -
Carriage Rate and Effects of Vaccination after Outbreaks of Serogroup C Meningococcal Disease, Brazil, 2010
por: Sáfadi, Marco Aurelio Palazzi, et al.
Publicado: (2014) -
Meningococcal disease before and after the introduction of meningococcal serogroup C conjugate vaccine. Federal District, Brazil
por: Tauil, Márcia de Cantuária, et al.
Publicado: (2014) -
The Clinical Picture and Severity of Invasive Meningococcal Disease Serogroup W Compared With Other Serogroups in the Netherlands, 2015–2018
por: Loenenbach, Anna D, et al.
Publicado: (2020) -
Safety and immunogenicity of co-administered meningococcal serogroup B (4CMenB) vaccine: A literature review
por: Abitbol, Véronique, et al.
Publicado: (2023)